噻唑烷二酮类药物是一类新的治疗2型糖尿病和胰岛素抵抗的药物。
Thiazolidinediones (TZDs) are a new class of agents commonly used for the treatment of patients with type 2 diabetes or insulin resistance.
体检也显示出血压、胰岛素抵抗、腹部内脏脂肪、腰围和其它潜在心脏病警示信息以及糖尿病都得到了相应的改善。
Physical exams also showed that blood pressure, insulin resistance, visceral abdominal fat, waist circumference and other warning signs of impending heart disease and diabetes were improved.
导致糖尿病的对胰岛素的抵抗看来是由聚积在肌肉细胞和肝脏内的脂肪引起的。
The resistance to insulin that leads to diabetes appears to be caused by a build-up of fat inside the muscle cells and also inside the liver.
应用推荐